Lifeboat Foundation

While it is still unclear how cryptocurrencies will alter in value and where we will be in 2023 — one thing is clear, they are undoubtedly here to stay.

As 2022 draws to a close, the cryptocurrency market is under great scrutiny. From the crypto winter of 2021 that saw Bitcoin lose almost a third of its value and other cryptocurrencies follow suit to security issues with crypto exchanges, bridges, and web 3.0 apps, and of course, FTX’s dramatic failure, it’s almost impossible to disbelieve tales of gloom. However, looking at the forecasts for 2023, it appears the market may rebound, and now may even be an ideal moment to invest.

Continue reading “Why blockchain will remain a big deal in 2023 and beyond” »

The new concept car will be “electric, circular, and digital.”

The future BMW plan calls for a large number of new electric vehicles. The company already has a strong portfolio of electric vehicles, but its new platform will only be focused on electrification.

BMW CFO Dr. Nicolas Peter previously announced at the end of the Q3 2022 quarterly report that BMW will unveil a new Vision Car at the upcoming CES 2023. “The next highlight on our way to the Neue Klasse will follow in January 2023. At the CES in Las Vegas, we will be presenting a visionary vehicle that will underpin our digital expertise. The future of the BMW Group is electric, circular, and digital,” Peter said.

In theory, it could mitigate the effects of global warming; but experts are wary.

Make Sunsets, a California-based startup, released weather balloons that carried sulfur particles into the stratosphere which possibly burst there, releasing the chemical, MIT Technology Review.

Continue reading “US startup wants to inject sulfur into the atmosphere to cool down the Earth” »

Many users on Twitter claim that OpenAI’s ChatGPT write and review codes within seconds. The company notes that ChatGPT is designed to offer a simpler, jargon-free reply to users.

There could be variables beyond the ones we’ve identified and know how to measure. But they can’t get rid of quantum weirdness.

In this article, we review the top 10 NFTs and why they make for great investments this year.

Non-Fungible Tokens, or NFTs for short, have been the buzzword for the year 2022. And, rightly so because even though it might seem like it is a new tech on the block, you will be shocked to know that there are more than 11 million NFTs out there. Each represents a unique (and, not to forget, valuable) piece of art which could be an image, video content, music, or anything else. And, yet, the industry is still in its infancy stage. We bring to you the only guide you will ever need to understand the uprising of the NFT market and what is all the attraction about. We have also shared some of our favorite NFTs to check out if you want to get active in space. This article features the top 10 NFTs that you should look out for in 2023.

Silks.

Cognitive science sees the brain as a sort of computer, but how does education redesign these cerebral computers? Cognitive scientist, philosopher, and expert on consciousness Daniel Dennett explains.
Watch the Q&A: https://youtu.be/0GJa0xKKSOU
Subscribe for regular science videos: http://bit.ly/RiSubscRibe.

Buy Daniel Dennet’s most recent book “From Bacteria to Bach and Back: The Evolution of Minds” — https://geni.us/4pTW46

Continue reading “If Brains are Computers, Who Designs the Software? — with Daniel Dennett” »

Ubik radio ads by Kobi LaCroix. Inspired by the Philip K. Dick novel “Ubik” (1969).

Kobi was nominated for a Logan Award for comedy music for his song “We Are The Vikings.” He was also featured on the Weird Al tribute album “Twenty-Six And A Half.” His music has been featured several times on the Dementia Top Twenty, Dementia Radio, the Mad Music Archive, and Dr. Demento. His website is at www.zencavern.com

Welder from Greater Manchester said he ‘wouldn’t be here’ without the trial Related video: Promising Drug Trial Appears to Cure Cancer Patients A man who was told he only has 12 months to live is now free of cancer thanks to a new drug trial.